Skip to main content
. 2013 Sep 11;2013(9):CD004289. doi: 10.1002/14651858.CD004289.pub5

Ahmadi 2005.

Methods

  • Study design: parallel RCT

  • Time frame: NR

  • Follow‐up period: 3 months
Participants

  • Country: Iran

  • Setting: multicentre

  • Inclusion criteria: chronic HD patients CRP > 10 mg/L

  • Number (treatment/control): 14/13

  • Age (mean ± SD) years: treatment group (57 ± 8); control group (56 ± 9)

  • Sex (M/F): unclear

  • Exclusion criteria: patients with illnesses or drugs that may affect CRP levels
Interventions Treatment group

  • Lovastatin

    • 20 mg daily

    • Treatment duration: 3 months


Control group

  • No medications
Outcomes

  • Hb levels

  • CRP levels
Notes Abstract only
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk NR
Allocation concealment (selection bias) Unclear risk NR
Blinding of participants and personnel (performance bias) 
 All outcomes High risk Not blinded
Blinding of outcome assessment (detection bias) 
 All outcomes High risk Not blinded
Incomplete outcome data (attrition bias) 
 All outcomes Unclear risk NR
Selective reporting (reporting bias) High risk Published reports did not include all expected outcomes
ITT analysis Unclear risk NR